Discontinued — last reported Q3 '23
West Pharmaceutical Services Delivery Systems — Revenue increased by 6.7% to $144.90M in Q3 2023 compared to the prior quarter. Year-over-year, this metric grew by 20.8%, from $120.00M to $144.90M. This is a positive signal — higher values indicate stronger performance for this metric.
Increasing revenue indicates strong market adoption and successful commercialization of proprietary delivery technologies.
This metric represents the total net sales generated by the Delivery Systems business segment. It reflects the market de...
Comparable to segment-specific net sales reported by other medical device or pharmaceutical packaging manufacturers.
wst_segment_delivery_systems_revenues| Q2 '21 | Q3 '21 | Q2 '22 | Q3 '22 | Q2 '23 | Q3 '23 | |
|---|---|---|---|---|---|---|
| Value | $136.40M | $129.70M | $117.80M | $120.00M | $135.80M | $144.90M |
| QoQ Change | — | -4.9% | -9.2% | +1.9% | +13.2% | +6.7% |
| YoY Change | — | — | -13.6% | -7.5% | +15.3% | +20.8% |